SB 1505 would substantially revise the Texas Compassionate-Use Program for low-THC cannabis. It expands how dispensing organizations may operate by authorizing one or more approved satellite locations for secure storage, requiring the Department of Public Safety to adopt security and design rules for those sites, and limiting the state to no more than six dispensing licenses while directing the department to ensure access across public health regions. The bill also requires a licensed dispensing organization to begin dispensing within 24 months of licensure and to maintain operations, with rules for monitoring and revocation if a license holder does not actually dispense cannabis.
The bill also changes patient access and product rules. It updates the definition of low-THC cannabis to a maximum of five milligrams of THC per dosage unit, allows prescriptions for a 90-day supply, and adds a new provision allowing physicians to prescribe pulmonary inhalation of aerosolized or vaporized low-THC cannabis when medically necessary. The measure broadens and clarifies qualifying conditions, including epilepsy, seizure disorders, multiple sclerosis, spasticity, ALS, autism, cancer, incurable neurodegenerative disease, PTSD, and certain research-program conditions. It also prohibits dispensing low-THC cannabis in packages containing more than 300 milligrams of THC and bars local governments from prohibiting cultivation, production, storage, dispensing, or possession authorized by state law.
The bill would amend both the Health and Safety Code and the Occupations Code, affecting the licensing and regulation of dispensing organizations, physician prescribing authority, and the scope of lawful medical cannabis use in Texas. It also directs DPS and HHSC to adopt implementing rules by October 1, 2025, and sets an effective date of September 1, 2025. In practical terms, the bill would create a more structured statewide medical cannabis distribution system while expanding the forms of administration available to patients.
The available legislative history shows strong support in committee: SB 1505 was reported favorably by the Senate State Affairs Committee on a 11-0 vote. No committee transcript or floor debate was provided, so the broader public or member sentiment cannot be measured from the supplied materials, but the recorded vote indicates consensus at the committee stage.
The main points of contention suggested by the bill text are regulatory and policy choices rather than explicit debate in the record provided. Potentially disputed issues include the cap of six licenses, the requirement that license holders begin dispensing within 24 months, the THC-per-dosage-unit limit, and the new authorization for pulmonary inhalation. The bill also preempts local restrictions, which could be controversial for municipalities and counties that want to regulate or limit cannabis-related activity within their borders.
SB 1505 would amend Chapter 487 of the Health and Safety Code and Chapter 169 of the Occupations Code to expand and tighten the regulatory framework for Texas’s low-THC cannabis program. It would authorize satellite storage locations, impose operational and licensing requirements on dispensing organizations, limit package THC content, expand physician prescribing options, and preempt local governments from banning authorized low-THC cannabis activity. The bill also requires new administrative rules from DPS and HHSC, affecting licensed dispensing organizations, physicians, patients in the compassionate-use registry, and local governments.
The only recorded vote provided is a unanimous 11-0 favorable report from the Senate State Affairs Committee, which suggests the bill was received positively at the committee stage. No hearing transcript or opposing vote record was included, so there is no direct evidence of broader opposition in the supplied materials. Based on the text, the bill appears to be framed as an access-and-administration expansion with regulatory guardrails, which may have helped support it in committee.
The likely areas of contention are the bill’s expansion of medical cannabis access versus its continued regulatory limits. Supporters would likely favor the added satellite locations, broader qualifying conditions, pulmonary inhalation option, and statewide access mandate, while critics may object to the preemption of local control, the THC limits, and the cap of six licenses. The requirement that license holders begin dispensing within 24 months and the authority to revoke inactive licenses could also be debated by prospective licensees and regulators because it imposes a stronger performance standard on dispensing organizations.